ArticleCell transplantation

Factors Associated with Costs in Chimeric Antigen Receptor T-Cell Therapy for Patients with Relapsed/Refractory B-Cell Malignancies.

Feng Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.